Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine in Irritable Bowel Syndrome
NCT00626288Phase 3Completed
- Sponsor
- SOFAR
- Start
- Dec 2007
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in irritable bowel syndrome (IBS), sponsored by SOFAR. Started Dec 2007; status: completed.
02
Drugs
Salcrozine
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00626288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626288.